Journal Article

How accurately does PSMA inhibitor 18F-DCFPyL-PET-CT image prostate cancer?

Clinical Cancer Research (2021) 27(13) 3512-3514
DOI: 10.1158/1078-0432.CCR-21-0749
8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Current techniques for imaging prostate cancer (CT, MRI, and PETagents18F-fluorodeoxyglucose,11C-choline,11C-acetate,and18Ffluciclovine)arelimitedinsensitivityandspecificity.PSMAPETagent 68Ga-PSMA-11 has recently been approved by the FDA. We comment on the performance of novel PSMA agent 18F-DCFPyL-PET/CT.

Cite

CITATION STYLE

APA

True, L. D., & Chen, D. L. (2021). How accurately does PSMA inhibitor 18F-DCFPyL-PET-CT image prostate cancer? Clinical Cancer Research, 27(13), 3512–3514. https://doi.org/10.1158/1078-0432.CCR-21-0749

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free